Breast Cancer,HER2+ HER2DX Test Correlates with Trastuzumab/Pertuzumab Therapy in HER2+/HR+ Breast Cancer Mar 14, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Adjuvant Olaparib Improves OS in High-Risk EBC: OlympiA Phase III Mar 09, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) A Phase 3 ASCENT Study on Sacituzumab Govitecan in mTNBC and HRQoL Mar 09, 2023
Breast Cancer,HER2+ Comparing Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in HER2+ Metastatic Breast Cancer Phase 3 Trial Feb 24, 2023
Breast Cancer,HER2+ Adjuvant T-DM1 vs. Trastuzumab in Residual HER2+ Breast Cancer: KATHERINE Phase 3 Results Feb 24, 2023